1don MSN
Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...
Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, ...
Editas Medicine struggles with underwhelming data and lacks major partnerships. Find out why EDIT stock faces significant ...
A recent study showcases the power of CRISPR gene editing to significantly boost the production of resveratrol, a ...
Collaborative research defines a novel approach to understanding how certain proteins called transcription factors determine which genetic programs will drive cell growth and maturation. The method, ...
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Cell And Gene Therapy Market Size and ForecastThe global cell and gene therapy market is projected to witness significant ...
Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) ...
When Integrated DNA Technologies (IDT) launched its Collab Network in February 2023, the goal was to speed up the pace of ...
The pilot project is being taken up in three districts of East and West Singhbhum and Seraikela-Kharsawan districts where ...
Scientists used CRISPR gene editing to create a banana that stays yellow longer, reducing food waste and extending shelf life ...
4d
Zacks.com on MSNThe Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR TherapeuticsIllumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics are part of the Zacks top Analyst Blog ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results